|
English
|
正體中文
|
简体中文
|
总笔数 :0
|
|
造访人次 :
52885226
在线人数 :
748
教育部委托研究计画 计画执行:国立台湾大学图书馆
|
|
|
"on the behalf of taiwan clinic"的相关文件
显示项目 1-5 / 5 (共1页)
1
每页显示[10|25|50]项目
| 臺大學術典藏 |
2022-06-27T06:59:50Z |
Risk of sepsis among patients with COPD treated with fixed combinations of inhaled corticosteroids and long-acting Beta2 agonists
|
Wang C.-Y.; Lin Y.S.; Wang Y.-H.; Lai C.-C.; Wang H.-C.; Chen L.; CHONG-JEN YU; CHONG-JEN YU; Wang H.-C.; Perng D.-W.; Cheng S.-L.; Hsu J.-Y.; Hsu W.-H.; Tsai Y.-H.; Hsiue T.-R.; Lin M.-C.; Lin H.-I.; Wang C.-Y.; Chang Y.-C.; Yang U.-C.; Chen C.-M.; Lin C.-S.; Chen L.; Wei Y.-F.; Chong I.-W.; Chen C.-Y.; On the behalf of Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE) |
| 臺大學術典藏 |
2021-03-19T06:57:17Z |
Risk of sepsis among patients with COPD treated with fixed combinations of inhaled corticosteroids and long-acting Beta2 agonists
|
Wang C.-Y.;Lin Y.S.;Wang Y.-H.;Lai C.-C.;Wang H.-C.;Chen L.;Yu C.-J.;Yu C.-J.;Wang H.-C.;Perng D.-W.;Cheng S.-L.;Hsu J.-Y.;Hsu W.-H.;Tsai Y.-H.;Hsiue T.-R.;Lin M.-C.;Lin H.-I.;Wang C.-Y.;Yeun-Chung Chang;Yang U.-C.;Chen C.-M.;Lin C.-S.;Chen L.;Wei Y.-F.;Chong I.-W.;Chen C.-Y.;On The Behalf Of Taiwan Clinical Trial Consortium For Respiratory Diseases (Tcore); Wang C.-Y.; Lin Y.S.; Wang Y.-H.; Lai C.-C.; Wang H.-C.; Chen L.; Yu C.-J.; Yu C.-J.; Wang H.-C.; Perng D.-W.; Cheng S.-L.; Hsu J.-Y.; Hsu W.-H.; Tsai Y.-H.; Hsiue T.-R.; Lin M.-C.; Lin H.-I.; Wang C.-Y.; YEUN-CHUNG CHANG; Yang U.-C.; Chen C.-M.; Lin C.-S.; Chen L.; Wei Y.-F.; Chong I.-W.; Chen C.-Y.; On the behalf of Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE) |
| 臺大學術典藏 |
2020-08-12T07:46:56Z |
Risk of sepsis among patients with COPD treated with fixed combinations of inhaled corticosteroids and long-acting Beta2 agonists
|
Chen C.-Y.; On the behalf of Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE); Lai C.-C.; HAO-CHIEN WANG; Chen L.; Yu C.-J.; Yu C.-J.; HAO-CHIEN WANG; Perng D.-W.; Cheng S.-L.; Hsu J.-Y.; Hsu W.-H.; Tsai Y.-H.; Hsiue T.-R.; Lin M.-C.; Lin H.-I.; Wang C.-Y.; Chang Y.-C.; Yang U.-C.; Chen C.-M.; Lin C.-S.; Chen L.; Wei Y.-F.; Chong I.-W.; Wang Y.-H.; Lin Y.S.; Wang C.-Y.; Wang C.-Y.;Lin Y.S.;Wang Y.-H.;Lai C.-C.;Hao-Chien Wang;Chen L.;Yu C.-J.;Yu C.-J.;Hao-Chien Wang;Perng D.-W.;Cheng S.-L.;Hsu J.-Y.;Hsu W.-H.;Tsai Y.-H.;Hsiue T.-R.;Lin M.-C.;Lin H.-I.;Wang C.-Y.;Chang Y.-C.;Yang U.-C.;Chen C.-M.;Lin C.-S.;Chen L.;Wei Y.-F.;Chong I.-W.;Chen C.-Y.;On The Behalf Of Taiwan Clinical Trial Consortium For Respiratory Diseases (Tcore) |
| 臺大學術典藏 |
2020-08-12T06:34:18Z |
Risk of sepsis among patients with COPD treated with fixed combinations of inhaled corticosteroids and long-acting Beta2 agonists
|
Wang C.-Y.; Lin Y.S.; Wang Y.-H.; Lai C.-C.; Wang H.-C.; Chen L.; CHONG-JEN YU; CHONG-JEN YU; Wang H.-C.; Perng D.-W.; Cheng S.-L.; Hsu J.-Y.; Hsu W.-H.; Tsai Y.-H.; Hsiue T.-R.; Lin M.-C.; Lin H.-I.; Wang C.-Y.; Chang Y.-C.; Yang U.-C.; Chen C.-M.; Lin C.-S.; Chen L.; Wei Y.-F.; Chong I.-W.; Chen C.-Y.; On the behalf of Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE); Wang C.-Y.;Lin Y.S.;Wang Y.-H.;Lai C.-C.;Wang H.-C.;Chen L.;Chong-Jen Yu;Chong-Jen Yu;Wang H.-C.;Perng D.-W.;Cheng S.-L.;Hsu J.-Y.;Hsu W.-H.;Tsai Y.-H.;Hsiue T.-R.;Lin M.-C.;Lin H.-I.;Wang C.-Y.;Chang Y.-C.;Yang U.-C.;Chen C.-M.;Lin C.-S.;Chen L.;Wei Y.-F.;Chong I.-W.;Chen C.-Y.;On The Behalf Of Taiwan Clinical Trial Consortium For Respiratory Diseases (Tcore) |
| 國家衛生研究院 |
2018-10-09 |
Risk of sepsis and mortality among patients with chronic obstructive pulmonary disease treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers
|
Lai, CC;Wang, YH;Wang, CY;Wang, HC;Yu, CJ;Chen, L;on the behalf of Taiwan Clinical Trial Consortium for Respiratory Diseases(TCORE) |
显示项目 1-5 / 5 (共1页)
1
每页显示[10|25|50]项目
|
